1-100462868-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_003672.4(CDC14A):​c.825C>T​(p.Ala275Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0107 in 1,613,466 control chromosomes in the GnomAD database, including 1,538 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.056 ( 834 hom., cov: 32)
Exomes 𝑓: 0.0060 ( 704 hom. )

Consequence

CDC14A
NM_003672.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.645

Publications

4 publications found
Variant links:
Genes affected
CDC14A (HGNC:1718): (cell division cycle 14A) The protein encoded by this gene is a member of the dual specificity protein tyrosine phosphatase family. It is highly similar to Saccharomyces cerevisiae Cdc14, a protein tyrosine phosphatase involved in the exit of cell mitosis and initiation of DNA replication, suggesting a role in cell cycle control. This protein has been shown to interact with, and dephosphorylate tumor suppressor protein p53, and is thought to regulate the function of p53. Alternative splicing of this gene results in several transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
CDC14A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic deafness 105
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal recessive nonsyndromic hearing loss 32
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, PanelApp Australia
  • hearing impairment and infertile male syndrome
    Inheritance: AR Classification: STRONG Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 1-100462868-C-T is Benign according to our data. Variant chr1-100462868-C-T is described in ClinVar as Benign. ClinVar VariationId is 517533.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.645 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.193 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDC14ANM_003672.4 linkc.825C>T p.Ala275Ala synonymous_variant Exon 9 of 16 ENST00000336454.5 NP_003663.2 Q9UNH5-1Q59EF4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDC14AENST00000336454.5 linkc.825C>T p.Ala275Ala synonymous_variant Exon 9 of 16 1 NM_003672.4 ENSP00000336739.3 Q9UNH5-1

Frequencies

GnomAD3 genomes
AF:
0.0563
AC:
8548
AN:
151920
Hom.:
829
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.196
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0194
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000834
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.000662
Gnomad OTH
AF:
0.0393
GnomAD2 exomes
AF:
0.0154
AC:
3861
AN:
250904
AF XY:
0.0111
show subpopulations
Gnomad AFR exome
AF:
0.204
Gnomad AMR exome
AF:
0.00940
Gnomad ASJ exome
AF:
0.00695
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000829
Gnomad OTH exome
AF:
0.00768
GnomAD4 exome
AF:
0.00598
AC:
8742
AN:
1461428
Hom.:
704
Cov.:
30
AF XY:
0.00521
AC XY:
3790
AN XY:
727032
show subpopulations
African (AFR)
AF:
0.200
AC:
6681
AN:
33450
American (AMR)
AF:
0.0109
AC:
489
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00524
AC:
137
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39656
South Asian (SAS)
AF:
0.000638
AC:
55
AN:
86206
European-Finnish (FIN)
AF:
0.0000749
AC:
4
AN:
53408
Middle Eastern (MID)
AF:
0.0130
AC:
75
AN:
5764
European-Non Finnish (NFE)
AF:
0.000451
AC:
501
AN:
1111722
Other (OTH)
AF:
0.0132
AC:
799
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
391
782
1172
1563
1954
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0564
AC:
8579
AN:
152038
Hom.:
834
Cov.:
32
AF XY:
0.0545
AC XY:
4052
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.196
AC:
8129
AN:
41440
American (AMR)
AF:
0.0191
AC:
292
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000626
AC:
3
AN:
4794
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10590
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.000662
AC:
45
AN:
67980
Other (OTH)
AF:
0.0389
AC:
82
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
339
679
1018
1358
1697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0230
Hom.:
857
Bravo
AF:
0.0633
Asia WGS
AF:
0.0110
AC:
38
AN:
3478
EpiCase
AF:
0.000709
EpiControl
AF:
0.00124

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Aug 23, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ala275Ala in exon 9 of CDC14A: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence, and has been identified in 19.94% (2053/10294) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; dbSNP rs7543221). -

Oct 05, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
4.2
DANN
Benign
0.92
PhyloP100
-0.65
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7543221; hg19: chr1-100928424; API